keyword
https://read.qxmd.com/read/38648093/a-tale-of-endurance-bats-viruses-and-immune-dynamics
#1
REVIEW
Apoorva, Sunit Kumar Singh
The emergence of highly zoonotic viral infections has propelled bat research forward. The viral outbreaks including Hendra virus, Nipah virus, Marburg virus, Ebola virus, Rabies virus, Middle East respiratory syndrome coronavirus, SARS-CoV and the latest SARS-CoV-2 have been epidemiologically linked to various bat species. Bats possess unique immunological characteristics that allow them to serve as a potential viral reservoir. Bats are also known to protect themselves against viruses and maintain their immunity...
April 22, 2024: Future Microbiology
https://read.qxmd.com/read/38646883/gs-441524-diphosphate-ribose-derivatives-as-nanomolar-binders-and-fluorescence-polarization-tracers-for-sars-cov-2-and-other-viral-macrodomains
#2
JOURNAL ARTICLE
Kewen Peng, Shamar D Wallace, Saket R Bagde, Jialin Shang, Ananya Anmangandla, Sadhan Jana, J Christopher Fromme, Hening Lin
Viral macrodomains that can bind to or hydrolyze protein adenosine diphosphate ribosylation (ADP-ribosylation) have emerged as promising targets for antiviral drug development. Many inhibitor development efforts have been directed against the severe acute respiratory syndrome coronavirus 2 macrodomain 1 (SARS-CoV-2 Mac1). However, potent inhibitors for viral macrodomains are still lacking, with the best inhibitors still in the micromolar range. Based on GS-441524 , a remdesivir precursor, and our previous studies, we have designed and synthesized potent binders of SARS-CoV-2 Mac1 and other viral macrodomains including those of Middle East respiratory syndrome coronavirus (MERS-CoV), Venezuelan equine encephalitis virus (VEEV), and Chikungunya virus (CHIKV)...
April 22, 2024: ACS Chemical Biology
https://read.qxmd.com/read/38633555/bibliometric-analysis-of-the-publications-on-middle-east-respiratory-syndrome-coronavirus-published-between-2012-2022
#3
JOURNAL ARTICLE
Sevil Alkan, Esra Gürbüz
OBJECTIVE: This study aimed to conduct a bibliometric analysis of the global scientific output related to the Middle East Respiratory Syndrome Coronavirus (MERS-CoV) between 2012 and 2022. MATERIALS AND METHODS: The Web of Science database was searched for articles on MERS-CoV published between 2012 and 2022 for bibliometric analysis. The parameters such as publication year, publication type, funding agencies, research institutions, journals, impact factors, language, and citation numbers of articles were analyzed...
September 2023: Infect Dis Clin Microbiol
https://read.qxmd.com/read/38624231/ns7a-of-sads-cov-promotes-viral-infection-via-inducing-apoptosis-to-suppress-type-iii-interferon-production
#4
JOURNAL ARTICLE
Xiaowei Wang, Wenjing Qiu, Guangli Hu, Xiaoyuan Diao, Yunfei Li, Yue Li, Peng Li, Yufang Liu, Yongtong Feng, Chunyi Xue, Yongchang Cao, Zhichao Xu
Swine acute diarrhea syndrome coronavirus (SADS-CoV) is a newly discovered swine coronavirus with potential cross-species transmission risk. Although SADS-CoV-induced host cell apoptosis and innate immunity antagonization has been revealed, underlying signaling pathways remain obscure. Here, we demonstrated that infection of SADS-CoV induced apoptosis in vivo and in vitro , and that viral protein NS7a is mainly responsible for SADS-CoV-induced apoptosis in host cells. Furthermore, we found that NS7a interacted with apoptosis-inducing factor mitochondria associated 1 (AIFM1) to activate caspase-3 via caspase-6 in SADS-CoV-infected cells, and enhanced SADS-CoV replication...
April 16, 2024: Journal of Virology
https://read.qxmd.com/read/38623540/sars-cov-2-infected-human-airway-epithelial-cell-cultures-uniquely-lack-interferon-and-immediate-early-gene-responses-caused-by-other-coronaviruses
#5
JOURNAL ARTICLE
Ying Wang, Melissa Thaler, Clarisse Salgado-Benvindo, Nathan Ly, Anouk A Leijs, Dennis K Ninaber, Philip M Hansbro, Fia Boedijono, Martijn J van Hemert, Pieter S Hiemstra, Anne M van der Does, Alen Faiz
OBJECTIVES: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a member of a class of highly pathogenic coronaviruses. The large family of coronaviruses, however, also includes members that cause only mild symptoms, like human coronavirus-229E (HCoV-229E) or OC43 (HCoV-OC43). Unravelling how molecular (and cellular) pathophysiology differs between highly and low pathogenic coronaviruses is important for the development of therapeutic strategies. METHODS: Here, we analysed the transcriptome of primary human bronchial epithelial cells (PBEC), differentiated at the air-liquid interface (ALI) after infection with SARS-CoV-2, SARS-CoV, Middle East Respiratory Syndrome (MERS)-CoV and HCoV-229E using bulk RNA sequencing...
2024: Clinical & Translational Immunology
https://read.qxmd.com/read/38622352/covid-19-drug-discovery-and-treatment-options
#6
REVIEW
Jasper Fuk-Woo Chan, Shuofeng Yuan, Hin Chu, Siddharth Sridhar, Kwok-Yung Yuen
The coronavirus disease 2019 (COVID-19) pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused substantial morbidity and mortality, and serious social and economic disruptions worldwide. Unvaccinated or incompletely vaccinated older individuals with underlying diseases are especially prone to severe disease. In patients with non-fatal disease, long COVID affecting multiple body systems may persist for months. Unlike SARS-CoV and Middle East respiratory syndrome coronavirus, which have either been mitigated or remained geographically restricted, SARS-CoV-2 has disseminated globally and is likely to continue circulating in humans with possible emergence of new variants that may render vaccines less effective...
April 15, 2024: Nature Reviews. Microbiology
https://read.qxmd.com/read/38617298/mapping-immunodominant-sites-on-the-mers-cov-spike-glycoprotein-targeted-by-infection-elicited-antibodies-in-humans
#7
Amin Addetia, Cameron Stewart, Albert J Seo, Kaitlin R Sprouse, Ayed Y Asiri, Maha Al-Mozaini, Ziad A Memish, Abeer Alshukairi, David Veesler
Middle-East respiratory syndrome coronavirus (MERS-CoV) first emerged in 2012 and causes human infections in endemic regions. Most vaccines and therapeutics in development against MERS-CoV focus on the spike (S) glycoprotein to prevent viral entry into target cells. These efforts, however, are limited by a poor understanding of antibody responses elicited by infection along with their durability, fine specificity and contribution of distinct S antigenic sites to neutralization. To address this knowledge gap, we analyzed S-directed binding and neutralizing antibody titers in plasma collected from individuals infected with MERS-CoV in 2017-2019 (prior to the COVID-19 pandemic)...
April 2, 2024: bioRxiv
https://read.qxmd.com/read/38591240/differential-beta-coronavirus-infection-dynamics-in-human-bronchial-epithelial-organoids
#8
JOURNAL ARTICLE
Dongbin Park, Se-Mi Kim, Hobin Jang, Kanghee Kim, Ho Young Ji, Heedong Yang, Woohyun Kwon, Yeonglim Kang, Suhee Hwang, Hyunjoon Kim, Mark Anthony B Casel, Issac Choi, Jeong-Sun Yang, Joo-Yeon Lee, Young Ki Choi
The lower respiratory system serves as the target and barrier for beta-coronavirus (beta-CoV) infections. In this study, we explored beta-CoV infection dynamics in human bronchial epithelial (HBE) organoids, focusing on HCoV-OC43, SARS-CoV, MERS-CoV, and SARS-CoV-2. Utilizing advanced organoid culture techniques, we observed robust replication for all beta-CoVs, particularly noting that SARS-CoV-2 reached peak viral RNA levels at 72 h postinfection. Through comprehensive transcriptomic analysis, we identified significant shifts in cell population dynamics, marked by an increase in goblet cells and a concurrent decrease in ciliated cells...
April 2024: Journal of Medical Virology
https://read.qxmd.com/read/38584269/the-impact-of-conflict-on-infectious-disease-a-systematic-literature-review
#9
REVIEW
Valia Marou, Constantine I Vardavas, Katerina Aslanoglou, Katerina Nikitara, Zinovia Plyta, Jo Leonardi-Bee, Kirsty Atkins, Orla Condell, Favelle Lamb, Jonathan E Suk
BACKGROUND: Conflict situations, armed or not, have been associated with emergence and transmission of infectious diseases. This review aims to identify the pathways through which infectious diseases emerge within conflict situations and to outline appropriate infectious disease preparedness and response strategies. METHODS: A systematic review was performed representing published evidence from January 2000 to October 2023. Ovid Medline and Embase were utilised to obtain literature on infectious diseases in any conflict settings...
April 8, 2024: Conflict and Health
https://read.qxmd.com/read/38568967/sars-cov-2-nsp15-endoribonuclease-antagonizes-dsrna-induced-antiviral-signaling
#10
JOURNAL ARTICLE
Clayton J Otter, Nicole Bracci, Nicholas A Parenti, Chengjin Ye, Abhishek Asthana, Ebba K Blomqvist, Li Hui Tan, Jessica J Pfannenstiel, Nathaniel Jackson, Anthony R Fehr, Robert H Silverman, James M Burke, Noam A Cohen, Luis Martinez-Sobrido, Susan R Weiss
Severe acute respiratory syndrome coronavirus (SARS-CoV)-2 has caused millions of deaths since its emergence in 2019. Innate immune antagonism by lethal CoVs such as SARS-CoV-2 is crucial for optimal replication and pathogenesis. The conserved nonstructural protein 15 (nsp15) endoribonuclease (EndoU) limits activation of double-stranded (ds)RNA-induced pathways, including interferon (IFN) signaling, protein kinase R (PKR), and oligoadenylate synthetase/ribonuclease L (OAS/RNase L) during diverse CoV infections including murine coronavirus and Middle East respiratory syndrome (MERS)-CoV...
April 9, 2024: Proceedings of the National Academy of Sciences of the United States of America
https://read.qxmd.com/read/38565174/government-initiatives-for-research-ethics-during-covid-19-pandemic-in-korea
#11
JOURNAL ARTICLE
Young Su Park, Ock-Joo Kim
BACKGROUND: Despite the growing necessity for government-led policy changes on clinical research ethics during pandemic, the scope of previous literature is limited to Korean government's pandemic response strategies or reflections of research ethics at the level of institutions and academic societies. This paper examines the proactive policy changes and responses by the South Korean government in addressing the challenges and issues of research ethics against the backdrop of the urgency of rapid development and emergency supply of medical products during the coronavirus disease 2019 (COVID-19) pandemic...
April 1, 2024: Journal of Korean Medical Science
https://read.qxmd.com/read/38561124/development-and-preliminary-validation-of-a-mers-cov-elisa-for-serological-testing-of-camels-and-alpacas
#12
JOURNAL ARTICLE
Leanne McNabb, Peter A Durr, Ross Lunt, Jennifer Barr, Timothy E Adams, Lesley Pearce, Leo L M Poon, Ranawaka A P M Perera, Getnet Fekadu Demissie, Timothy R Bowden
This study describes the development and preliminary validation of a new serological assay using MERS-CoV S1 protein in an indirect enzyme-linked immunosorbent assay (ELISA) format. This assay has the advantage of being able to test MERS-CoV serum samples in a PC2 laboratory without the need for a high-level biocontainment laboratory (PC3 or PC4), which requires highly trained and skilled staff and a high level of resources and equipment. Furthermore, this MERS-CoV S1 ELISA enables a larger number of samples to be tested quickly, with results obtained in approximately five hours...
March 30, 2024: Journal of Virological Methods
https://read.qxmd.com/read/38559009/functional-assessment-of-cell-entry-and-receptor-use-for-merbecoviruses
#13
Michael Letko
The merbecovirus subgenus of coronaviruses includes Middle East Respiratory Syndrome Coronavirus (MERS-CoV), which is a zoonotic respiratory pathogen that transmits from dromedary camels to humans and causes severe respiratory disease. Viral discovery efforts have uncovered hundreds of merbecoviruses in different species across multiple continents, but few of these viruses have been isolated or studied under laboratory conditions, leaving basic questions regarding their threat to humans unresolved. Viral entry into host cells is considered an early and critical step for transmission between hosts...
March 14, 2024: bioRxiv
https://read.qxmd.com/read/38558973/protein-nanoparticle-vaccines-induce-potent-neutralizing-antibody-responses-against-mers-cov
#14
Cara W Chao, Kaitlin R Sprouse, Marcos C Miranda, Nicholas J Catanzaro, Miranda L Hubbard, Amin Addetia, Cameron Stewart, Jack T Brown, Annie Dosey, Adian Valdez, Rashmi Ravichandran, Grace G Hendricks, Maggie Ahlrichs, Craig Dobbins, Alexis Hand, Catherine Treichel, Isabelle Willoughby, Alexandra C Walls, Andrew T McGuire, Elizabeth M Leaf, Ralph S Baric, Alexandra Schäfer, David Veesler, Neil P King
Middle East respiratory syndrome coronavirus (MERS-CoV) is a zoonotic betacoronavirus that causes severe and often lethal respiratory illness in humans. The MERS-CoV spike (S) protein is the viral fusogen and the target of neutralizing antibodies, and has therefore been the focus of vaccine design efforts. Currently there are no licensed vaccines against MERS-CoV and only a few candidates have advanced to Phase I clinical trials. Here we developed MERS-CoV vaccines utilizing a computationally designed protein nanoparticle platform that has generated safe and immunogenic vaccines against various enveloped viruses, including a licensed vaccine for SARS-CoV-2...
March 14, 2024: bioRxiv
https://read.qxmd.com/read/38555743/differences-and-similarities-between-innate-immune-evasion-strategies-of-human-coronaviruses
#15
REVIEW
Helene Hoenigsperger, Rinu Sivarajan, Konstantin Mj Sparrer
So far, seven coronaviruses have emerged in humans. Four recurring endemic coronaviruses cause mild respiratory symptoms. Infections with epidemic Middle East respiratory syndrome-related coronavirus or severe acute respiratory syndrome coronavirus (SARS-CoV)-1 are associated with high mortality rates. SARS-CoV-2 is the causative agent of the coronavirus disease 2019 pandemic. To establish an infection, coronaviruses evade restriction by human innate immune defenses, such as the interferon system, autophagy and the inflammasome...
March 30, 2024: Current Opinion in Microbiology
https://read.qxmd.com/read/38531008/establishment-of-a-human-organoid-based-evaluation-system-for-assessing-interspecies-infection-risk-of-animal-borne-coronaviruses
#16
JOURNAL ARTICLE
Qianchun Gong, Rendi Jiang, Lina Ji, Haofeng Lin, Meiqin Liu, Xiaofang Tang, Yong Yang, Wei Han, Jing Chen, Zishuo Guo, Qi Wang, Qian Li, Xi Wang, Tingting Jiang, Shizhe Xie, Xinglou Yang, Peng Zhou, Zhengli Shi, Xinhua Lin
The COVID-19 pandemic presents a major threat to global public health. Several lines of evidence have shown that the Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2), along with two other highly pathogenic coronaviruses, SARS-CoV and Middle East Respiratory Syndrome (MERS-CoV) originated from bats. To prevent and control future coronavirus outbreaks, it is necessary to investigate the interspecies infection and pathogenicity risks of animal-related coronaviruses. Currently used infection models, including in vitro cell lines and in vivo animal models, fail to fully mimic the primary infection in human tissues...
December 2024: Emerging Microbes & Infections
https://read.qxmd.com/read/38523518/the-role-of-traditional-chinese-medicine-and-chinese-pharmacopoeia-in-the-evaluation-and-treatment-of-covid-19
#17
JOURNAL ARTICLE
Amin Gasmi, Sadaf Noor, Maryam Dadar, Yuliya Semenova, Alain Menzel, Asma Gasmi Benahmed, Geir Bjørklund
The epidemic prompted by COVID-19 continues to spread, causing a great risk to the general population's safety and health. There are still no drugs capable of curing it. Severe Acute Respiratory Syndrome (SARS) and Middle East Respiratory Syndrome (MERS) are the two other diseases caused by coronaviruses. Traditional Chinese Medicine (TCM) showed benefits in treating SARS and MERS by preventing the disease early, substantially mitigating symptoms, shortening the treatment period, and minimizing risks and adverse reactions caused by hormone therapy...
March 22, 2024: Current Pharmaceutical Design
https://read.qxmd.com/read/38508400/genetic-loci-regulate-sarbecovirus-pathogenesis-a-comparison-across-mice-and-humans
#18
JOURNAL ARTICLE
Alexandra Schäfer, Lisa E Gralinski, Sarah R Leist, Brea K Hampton, Michael A Mooney, Kara L Jensen, Rachel L Graham, Sudhakar Agnihothram, Sophia Jeng, Steven Chamberlin, Timothy A Bell, D Trevor Scobey, Colton L Linnertz, Laura A VanBlargan, Larissa B Thackray, Pablo Hock, Darla R Miller, Ginger D Shaw, Michael S Diamond, Fernando Pardo Manuel de Villena, Shannon K McWeeney, Mark T Heise, Vineet D Menachery, Martin T Ferris, Ralph S Baric
Coronavirus (CoV) cause considerable morbidity and mortality in humans and other mammals, as evidenced by the emergence of Severe Acute Respiratory CoV (SARS-CoV) in 2003, Middle East Respiratory CoV (MERS-CoV) in 2012, and SARS-CoV-2 in 2019. Although poorly characterized, natural genetic variation in human and other mammals modulate virus pathogenesis, as reflected by the spectrum of clinical outcomes ranging from asymptomatic infections to lethal disease. Using multiple human epidemic and zoonotic Sarbecoviruses, coupled with murine Collaborative Cross genetic reference populations, we identify several dozen quantitative trait loci that regulate SARS-like group-2B CoV pathogenesis and replication...
March 22, 2024: Virus Research
https://read.qxmd.com/read/38508059/understanding-long-covid-myocarditis-a-comprehensive-review
#19
JOURNAL ARTICLE
Arti Srivastava, Shankar Nalroad Sundararaj, Jagriti Bhatia, Dharamvir Singh Arya
Infectious diseases are a cause of major concern in this twenty-first century. There have been reports of various outbreaks like severe acute respiratory syndrome (SARS) in 2003, swine flu in 2009, Zika virus disease in 2015, and Middle East Respiratory Syndrome (MERS) in 2012, since the start of this millennium. In addition to these outbreaks, the latest infectious disease to result in an outbreak is the SARS-CoV-2 infection. A viral infection recognized as a respiratory illness at the time of emergence, SARS-CoV-2 has wreaked havoc worldwide because of its long-lasting implications like heart failure, sepsis, organ failure, etc...
March 18, 2024: Cytokine
https://read.qxmd.com/read/38495380/camel-urine-as-a-potential-source-of-bioactive-molecules-showing-their-efficacy-against-pathogens-a-systematic-review
#20
REVIEW
Ressmi Amina, Raqraq Habiba, Barguigua Abouddihaj
Camels are highly suited for severe desert conditions and able to provide most of the natural products like urine, which has been used as alternative medicine to treat diverse infections and disorders. There is, however, a shortage and paucity of scientific reviews highlighting the antifungal, antibacterial and antiviral effects of camel urine. By better understanding its antimicrobial characteristics, our overarching aim is to provide an exhaustive overview of this valuable natural product by synthesizing and summarizing data on the efficacy of this biofluid and also describing the potential substances exhibiting antimicrobial properties...
May 2024: Saudi Journal of Biological Sciences
keyword
keyword
167858
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.